Chemical biology core facility
Infrastructure and expertise for assay development, small-molecule screening and use of medicinal chemistry to optimise compounds against novel targets for 'biotool' or early drug development.
Developing new drugs and tools to understand the chemistry of life
Life is a series of chemical reactions. Chemistry powers individual cells and whole organisms, and allows them to communicate with each other. Cells have perfected the control of chemical reactions, for example by evolving various enzymes – proteins that are adapted to make specific chemical reactions occur more rapidly.
To understand more about the way life works, scientists can use chemical tools. Chemistry also allows scientists to develop new drugs that cure diseases by changing the activity of proteins or other molecules in the body.
At EMBL, chemistry is applied in various ways. The development of new chemical tools involves the design of molecules on the computer and their synthesis in the lab. These molecules can then be used to identify or tag other molecules in living cells, making it possible to observe them under the microscope. New tools also allow scientists to analyse all of a cell’s metabolites – the molecules that are produced by the chemical reactions taking place inside the cell.
To develop new drugs, several disciplines work closely together. At EMBL’s European Bioinformatics Institute (EMBL-EBI), computer programmes are developed for storing, searching, and analysing chemical data. These programmes allow scientists to predict the biological effects of specific molecules and help them to select interesting drug candidates. Engineering helps researchers by providing new technologies that enable thousands of molecules to be tested simultaneously for biological activity. Chemists can then modify these molecules further to enhance their properties. This approach can lead to the discovery of new drugs targeting common diseases, such as viral infections or cancer.
Infrastructure and expertise for assay development, small-molecule screening and use of medicinal chemistry to optimise compounds against novel targets for 'biotool' or early drug development.
EMBL is Europe’s life sciences laboratory – an intergovernmental organisation with more than 110 independent research groups and service teams covering the spectrum of molecular biology. It operates across six sites in Heidelberg (headquarters), Barcelona, Cambridge, Grenoble, Hamburg and Rome. Our...
Closes on 3rd March. Posted 29th January 2026
EditDo you want to lead groundbreaking research in computational biology? Join us at EMBL-EBI!EMBL's European Bioinformatics Institute (EMBL-EBI) is seeking talented and highly-motivated scientists to join its Faculty and develop their own independent research group. We welcome applicants from across th...
Closes on 12th April. Posted 29th January 2026
EditYour role MGnify is EMBL-EBI’s microbiome sequence data analysis resource, which performs the archiving, assembly and analysis of amplicon, metagenomic and metatranscriptomic data. Alongside the large-scale analysis of existing public microbiome datasets in ENA, we are participants in several projec...
Closes on 19th February. Posted 28th January 2026
EditFrom microscopy to mycology, from development to disease modelling, EMBL researchers cover a wide range of topics in the biological sciences.